Satvik Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1.68%
(FY 2023)
- Profit 137.76%
(FY 2023)
- Ebitda 49.36%
(FY 2023)
- Net Worth 15.19%
(FY 2023)
- Total Assets 0.13%
(FY 2023)
About Satvik Pharmaceuticals
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishan Jethani and Rita Jethani serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PTC146274
- Company No.
146274
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Satvik Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishan Jethani  | Director | 30-Apr-2005 | Current |
| Rita Jethani | Director | 30-Apr-2005 | Current |
Financial Performance of Satvik Pharmaceuticals.
Satvik Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.68% increase. The company also saw a substantial improvement in profitability, with a 137.76% increase in profit. The company's net worth Soared by an impressive increase of 15.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satvik Pharmaceuticals?
In 2023, Satvik Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- K K Stock Management Private LimitedActive 28 years 2 months
Krishan Jethani and Rita Jethani are mutual person
- Nikkei Denim Private LimitedActive 29 years 9 months
Krishan Jethani and Rita Jethani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Satvik Pharmaceuticals?
Unlock and access historical data on people associated with Satvik Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satvik Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satvik Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
